2388:HKEXBOC Hong Kong (Holdings) Limited Analysis
Data as of 2026-07-23 - not real-time
HK$48.36
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
BOC Hong Kong (Holdings) trades at a PE of 12.76, well below the regional banking average of 17.68, indicating a clear undervaluation. The stock offers an attractive 7.47% dividend yield with a 60% payout ratio, supported by robust earnings (profit margin 58% and operating margin 69%). Revenue has slipped slightly by 2.7%, but earnings remain strong and cash reserves are massive at HK$689 billion, dwarfing the HK$150 billion debt load. Technicals show a bullish MACD and an RSI of 65, suggesting momentum is still intact, while the price sits just below the recent resistance of HK$48.48 and above the support of HK$41.82. The low beta (≈0.22) and a 30% 30‑day volatility point to modest price swings, and the market’s “Extreme Greed” sentiment (FGI 88) adds a positive bias. Analysts’ consensus is a Buy with a mean target of HK$48.59, implying modest upside from the current HK$48.36 level. Overall, the combination of valuation discount, high dividend, solid capital base, and favorable technical signals makes the stock appealing for income‑focused investors.
Given the neutral trend direction and decreasing volume, short‑term price action may oscillate around the resistance zone, but the fundamental backdrop remains resilient. The low liquidity risk, modest sector risk, and limited currency exposure further reinforce a stable risk profile, supporting a longer‑term hold or accumulation strategy.
Given the neutral trend direction and decreasing volume, short‑term price action may oscillate around the resistance zone, but the fundamental backdrop remains resilient. The low liquidity risk, modest sector risk, and limited currency exposure further reinforce a stable risk profile, supporting a longer‑term hold or accumulation strategy.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD but price near resistance
- High dividend yield offering immediate income
- Decreasing volume indicating potential short‑term consolidation
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued PE relative to industry peers
- Sustained high dividend yield with solid payout ratio
- Target price above current level suggesting modest upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong balance sheet with ample cash and low leverage
- Low beta and modest volatility supporting stability
- Consistent profitability and attractive dividend income
Key Metrics & Analysis
Financial Health
Revenue Growth-2.70%
Profit Margin58.38%
P/E Ratio12.8
ROE11.67%
ROA0.95%
P/B Ratio1.4
Op. Cash FlowHK$-304603004928
Industry P/E17.7
Technical Analysis
TrendNeutral
RSI65.3
SupportHK$41.82
ResistanceHK$48.48
MA 20HK$45.40
MA 50HK$46.61
MA 200HK$41.91
MACDBullish
VolumeDecreasing
Fear & Greed Index88.04
Valuation
Target PriceHK$48.59
Upside/Downside0.48%
GradeUndervalued
TypeValue
Dividend Yield7.47%
Risk Assessment
Beta0.42
Volatility30.06%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.